Clinical Trial

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

Study acronym: Key-Early
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2025 (before its estimated June 24, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a non-interventional, retrospective observational study to improve knowledge regarding the diagnosis and treatments of patients who have/had non-small cell lung cancer (NSCLC), either early stage (stage I-II).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-14.
Status change: Not Yet Recruiting → Recruiting 2025-01-13
Trial Details
NCT Number NCT06467383
Lead Sponsor MSD Italia S.r.l.
Collaborators: YGHEA, CRO Division of Ecol Studio spa
Conditions Non-small Cell Lung Cancer, NSCLC, NSCLC, Stage III, NSCLC, Stage I
Enrollment 600 participants
Start Date 2024-06-25
Primary Completion 2025-06-24 (estimated)
Study Completion 2025-06-24 (estimated)
Updated on ClinicalTrials.gov 2025-01-14